FindTrial
Sign In

Paracetamol as a Tracer for Plasma Volume Measurements: a Proof of Principle study

Paracetamol as a Tracer for Plasma Volume Measurements: a Proof of Principle study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON23031
Enrollment
20
Registered
2019-12-18
Start date
2022-11-30
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(pre-)eclampsia

Interventions

vergelijking van de resultaten van de gouden standaard voor bepaling van plasmavolume met de berekende plasmavolumes door toediening van paracetamol

Sponsors

Maastricht UMC+
Lead Sponsor
dept. of Anesthesiology MUMC+
Collaborator

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: women of at least 18 years of age, (pre-)eclampsia in prior pregnancy, scheduled for PV measurement, agree to participate in the study

Exclusion criteria

Exclusion criteria: under the age of 18, pregnant, allergy for paracetamol, known to have liver disease which impairs the metabolism of paracetamol, acute liver failure, refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
determination if paracetamol can be used effectively and accurately in determining PV as compared to the gold standard—

Contacts

Public ContactNicole Engel

MUMC+

nicole.engel@mumc.nl0433877456

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)